Your browser doesn't support javascript.
loading
Long-term experience with intraoperative electron radiation therapy boost in extremity sarcoma.
Laughlin, Brady S; Golafshar, Michael A; Lin, Keldon; Goulding, Krista; Roesler, Kimberly; Vern-Gross, Tamara; Seetharam, Mahesh; Zaniletti, Isabella; Ashman, Jonathan B.
Afiliación
  • Laughlin BS; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Golafshar MA; Department of Qualitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA.
  • Lin K; Mayo Clinic Alix School of Medicine, Scottsdale, Arizona, USA.
  • Goulding K; Department of Orthopedic Surgery, Mayo Clinic, Phoenix, Arizona, USA.
  • Roesler K; School of Medicine, Creighton University, Omaha, Nebraska, USA.
  • Vern-Gross T; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Seetharam M; Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Zaniletti I; Department of Qualitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA.
  • Ashman JB; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA.
J Surg Oncol ; 126(7): 1279-1287, 2022 Dec.
Article en En | MEDLINE | ID: mdl-35856506
ABSTRACT

BACKGROUND:

In patients with extremity soft tissue sarcoma (eSTS), we describe outcomes of preoperative external beam radiation therapy (EBRT), limb-sparing surgery (LSS), and intraoperative electron radiation therapy (IOERT).

METHODS:

One hundred and eighteen patients with eSTS treated between October 17, 2002 and July 28, 2021 were identified. EBRT was delivered preoperatively followed by LSS and IOERT.

RESULTS:

The median follow-up was 24.9 months. The presentation was primary in 102 (94%) patients and recurrent in 6 (6%) patients. Tumor location was lower extremity in 82 (76%) patients and upper extremity in 26 (24%) patients. Stage distribution was as follows 3 (3%) IA, 24 (22%) IB, 31 (29%) II, 24 (22%) IIIA, and 25 (23%) IIIB. Final surgical margins were negative in 96 (89%) patients. The 5-year local control, failure-free survival, and overall survival were 94%, 75%, and 64%, respectively. Univariate analysis identified age >50, lower extremity, and higher grade as significant negative prognostic factors for overall survival. Grade 3 fracture or osteoradionecrosis requiring surgical fixation, neuropathy, and lymphedema occurred in 7 (6%), 1 (1%), and 0 patients, respectively.

CONCLUSIONS:

This study represents one of the largest series using preoperative EBRT, LSS, and IOERT for eSTS, with high local control and a low rate of late severe toxicity.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias de los Tejidos Blandos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Surg Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias de los Tejidos Blandos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Surg Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos